Live birth rate per woman · women undergoing assisted reproductive technology (ART)
GnRH antagonist showed no clear difference in live birth rate per woman randomised compared with long‐course GnRH agonist (moderate certainty).
1 finding from 1 review
OHSS per woman randomised (any grade) · women undergoing assisted reproductive technology (ART)
GnRH antagonist probably leads to lower OHSS per woman randomised (any grade) compared with long‐course GnRH agonist (moderate certainty).
1 finding from 1 review
Ongoing pregnancy · women undergoing assisted reproductive technology (ART)
GnRH antagonist showed no clear difference in ongoing pregnancy rate per woman randomised compared with long‐course GnRH agonist (moderate certainty).
1 finding from 1 review
Clinical pregnancy rate · women undergoing assisted reproductive technology (ART)
GnRH antagonist showed no clear difference in clinical pregnancy rate per woman randomised compared with long‐course GnRH agonist (moderate certainty).
1 finding from 1 review
Miscarriage · women undergoing assisted reproductive technology (ART)
GnRH antagonist showed no clear difference in miscarriage rate per woman randomised compared with long‐course GnRH agonist (moderate certainty).
1 finding from 1 review
Cycle cancellation due to poor ovarian response · women undergoing assisted reproductive technology (ART)
GnRH antagonist probably leads to higher cycle cancellation due to poor ovarian response compared with long‐course GnRH agonist (moderate certainty).
1 finding from 1 review
Live birth rate per couple · intrauterine insemination (IUI) in women with infertility
It is very uncertain whether gonadotropins with GnRH antagonist changes live birth rate per couple compared with gonadotropins alone (very low certainty).
1 finding from 1 review
Multiple pregnancy rate · intrauterine insemination (IUI) in women with infertility
Gonadotropins with GnRH antagonist showed no clear difference in multiple pregnancy rate per couple compared with gonadotropins alone (moderate certainty).
1 finding from 1 review
Clinical pregnancy rate · intrauterine insemination (IUI) in women with infertility
Gonadotropins with GnRH antagonist showed no clear difference in clinical pregnancy rate per couple compared with gonadotropins alone (low certainty).
1 finding from 1 review
Miscarriage · intrauterine insemination (IUI) in women with infertility
Gonadotropins with GnRH antagonist showed no clear difference in miscarriage rate per couple compared with gonadotropins alone (low certainty).
1 finding from 1 review
OHSS · intrauterine insemination (IUI) in women with infertility
It is very uncertain whether gonadotropins with GnRH antagonist changes OHSS rate per couple compared with gonadotropins alone (very low certainty).
1 finding from 1 review
Ectopic pregnancy rate per couple · intrauterine insemination (IUI) in women with infertility
Gonadotropins with GnRH antagonist showed no clear difference in ectopic pregnancy rate per couple compared with gonadotropins alone (low certainty).
1 finding from 1 review
Premature ovarian failure · premenopausal women with malignant conditions, receiving GnRH agonist before or in parallel to chemotherapy
1 finding from 1 review
no estimate extracted
0 participants
GRADE not reported
Pregnancy · premenopausal women with malignant conditions, receiving GnRH agonist before or in parallel to chemotherapy
It is very uncertain whether gnRH agonist‐antagonist cotreatment plus chemotherapy changes pregnancy compared with chemotherapy alone (very low certainty).
1 finding from 1 review
Ovulation · premenopausal women with malignant conditions, receiving GnRH agonist before or in parallel to chemotherapy
1 finding from 1 review
no estimate extracted
0 participants
GRADE not reported
Adverse events · premenopausal women with malignant conditions, receiving GnRH agonist before or in parallel to chemotherapy
1 finding from 1 review
no estimate extracted
0 participants
GRADE not reported
Menstruation recovery or maintenance: · premenopausal women with malignant conditions, receiving GnRH agonist before or in parallel to chemotherapy
It is very uncertain whether gnRH agonist‐antagonist cotreatment plus chemotherapy changes menstruation recovery or maintenance: compared with chemotherapy alone (very low certainty).
2 findings from 1 review